3651 results for «289»

Filter By

3651 results

CTO PCI: technical developments

19 May 2026 – From EuroPCR 2026

This session highlights technical developments in CTO PCI, featuring comparative insights from the ONUBA-CTO study on retrograde versus antegrade approaches, sex-based differences in long-term outcomes, management of balloon-undilatable lesions, the role of virtual reality audiovisual distraction, the impact of core laboratory feedback with OCT, and contemporary...

Behind standard practice: a place for DCB

19 May 2026 – From EuroPCR 2026

This session examines the role of drug-coated balloons (DCB) beyond standard practice in coronary revascularization. It includes discussions on revascularization strategies in young patients, rescue of early distal LIMA–LAD anastomosis, treatment of in-stent restenosis, stepwise complex CTO bifurcation revascularization using kissing DCBs, and management of calcified...

Mitral TEER beyond the routine: complex and complicated cases

19 May 2026 – From EuroPCR 2026

This session explores complex and complicated cases of mitral transcatheter edge-to-edge repair (TEER) beyond routine practice. It addresses challenges such as device failures, late complications, acute left ventricular dysfunction related to afterload changes, stepwise approaches to overcome procedural failures, rescue strategies in cardiogenic shock, and tailored...

Interventions for heart failure: insights and innovations

19 May 2026 – From EuroPCR 2026

This session presents innovations and insights into interventional treatments for heart failure. Topics include pulmonary artery denervation for combined pre- and post-capillary pulmonary hypertension, evaluation of extravascular ventricular assist devices, biomarker-guided therapy withdrawal in improved heart failure, outcomes of transcatheter iatrogenic atrial shunts, percutaneous balloon pericardiotomy...

PCI for complex left main disease

19 May 2026 – From EuroPCR 2026

This session delves into the complexities of percutaneous coronary intervention (PCI) for left main disease, emphasizing strategic approaches to dual critical lesions and innovative techniques such as excimer laser and drug-eluting balloons. It also explores hybrid strategies for treating in-stent restenosis and redo revascularisation, offering a...

CTO PCI: how to prevent and manage complications effectively?

19 May 2026 – From EuroPCR 2026

Focused on chronic total occlusion (CTO) PCI, this session highlights the critical importance of procedural planning to minimize complications. Through detailed case analyses of coronary dissection and perforation, it outlines early identification strategies and equips clinicians with essential tools and techniques for effective complication management in...

CTO PCI: how to prevent and manage complications effectively?

New evidence for pharmacology for coronary artery disease

19 May 2026 – From EuroPCR 2026

This session presents the latest evidence in pharmacological management of coronary artery disease, featuring pivotal trials such as VESALIUS-CV and TARGET FIRST. It covers topics including evolocumab efficacy post-stenting, early aspirin cessation strategies, aspirin-free protocols after complex PCI in ACS, and comparative outcomes of clopidogrel versus...

New evidence for pharmacology for coronary artery disease

Abstract submissions - Nurses and Allied Professionals

19 May 2026 – From EuroPCR 2026

Dedicated to nurses and allied professionals, this session addresses occupational health challenges, radiation dose reduction through AI-enhanced fluoroscopy, and innovative simulation techniques for ECMO-supported resuscitation. It also explores sustainable practices in cath labs and the integration of structured physiotherapy pathways within TAVI programmes, underscoring multidisciplinary contributions...

Artificial intelligence and advanced imaging in coronary interventions

19 May 2026 – From EuroPCR 2026

This session explores the integration of artificial intelligence with advanced imaging modalities in coronary interventions. Topics include quantitative myocardial blood flow assessment via co-registered CCTA and angiography, AI-guided real-time procedural support, novel video frame interpolation techniques, high-risk plaque identification through AI-derived OCT stress mapping, and validation...

Atrioventricular valve interventions in unusual clinical scenarios

19 May 2026 – From EuroPCR 2026

This session presents a series of complex atrioventricular valve interventions performed in unusual clinical scenarios, illustrating innovative approaches such as transcatheter tricuspid valve-in-valve post-heart transplant, dual mitral and tricuspid clipping via single access, and TEER in congenital heart anomalies. It highlights procedural complexities and novel solutions...

When calcium fights back: multinational insights into complex PCI and complication rescue

20 May 2026 – From EuroPCR 2026

This multinational session highlights advanced approaches to complex PCI involving heavily calcified coronary arteries. It aims to enhance mastery of contemporary calcium modification tools, reinforce decision-making skills in high-risk, complication-prone interventions, and optimize imaging-guided assessment of coronary calcium through illustrative cases from Bulgaria, Romania, and Tunisia.

Imaging the calcified lesions: what you need to see

20 May 2026 – From EuroPCR 2026

This session emphasizes critical imaging aspects necessary for assessing calcified coronary lesions. It addresses lesion-specific Agatston scoring, OCT-guided PCI optimization, coronary CT planning, histopathological insights, and predictors of stent underexpansion after calcium modification.

Major Late-Breaking Trials from EuroPCR 2026

20 May 2026 – From EuroPCR 2026

This session presents major late-breaking trials from EuroPCR 2026, reviewing contemporary evidence on coronary revascularization in TAVI patients, long-term outcomes of PCI versus CABG for left main disease, and comparative effectiveness of LAA closure versus NOAC in atrial fibrillation across age groups, with clinical practice implications.

Major Late-Breaking Trials from EuroPCR 2026

CTO BASIC Level II: LIVE Educational Cases from Institut Cardiovasculaire Paris Sud, France & University Hospital Basel, Switzerland

20 May 2026 – From EuroPCR 2026

This advanced CTO BASIC Level II session presents live educational cases from leading European centers in France and Switzerland. It focuses on higher-level antegrade CTO interventions, illustrating when to switch among antegrade techniques and how to utilize advanced tools effectively to improve procedural success, supported by...

CTO BASIC Level II: LIVE Educational Cases from Institut Cardiovasculaire Paris Sud, France & University Hospital Basel, Switzerland

Transcatheter mitral interventions: outcomes and new procedural approaches

20 May 2026 – From EuroPCR 2026

This session covers transcatheter mitral interventions, comparing surgical and transcatheter approaches, including TEER and TMVR. It presents clinical outcomes, safety data, and innovative procedural techniques such as transeptal BATMAN to prevent left ventricular outflow tract obstruction during TMVR.

Transcatheter mitral interventions: outcomes and new procedural approaches

Calcified coronary: LIVE Educational Case from Clinique Pasteur - Toulouse, France

20 May 2026 – From EuroPCR 2026

This live educational case from Clinique Pasteur in Toulouse, France, showcases the management of complex calcified coronary lesions through multimodality imaging guidance. It addresses the selection of plaque modification devices and discusses optimal stenting strategies for challenging calcified bifurcation lesions, complemented by live procedural insights and...

TAVI procedural complications - Part 5: vascular complications, coronary issues and more

20 May 2026 – From EuroPCR 2026

This session addresses procedural complications during TAVI, focusing on vascular complications, coronary issues, and rare device-related events. It includes case analyses of aortic dissection, valve infolding, stent dislodgement, and management strategies for complex anatomical challenges.

TAVI procedural complications - Part 5: vascular complications, coronary issues and more

Complications during left main PCI: how to manage and how to avoid

20 May 2026 – From EuroPCR 2026

This session addresses the identification, prevention, and management of complications arising during left main percutaneous coronary intervention (PCI). Through detailed case presentations and analyses, it highlights anatomical and procedural risk factors, strategies to anticipate and recognize complications such as stent deformation and coronary perforation, and effective...

Complications during left main PCI: how to manage and how to avoid

Tackling calcified lesions with IVUS guidance and optimisation

20 May 2026 – From EuroPCR 2026

This session delves into the critical role of Intravascular Ultrasound (IVUS) in characterizing and managing calcified coronary lesions. Attendees can explore an imaging-guided approach to calcium treatment, including case presentations that demonstrate stent selection and procedural optimization. Emphasis is placed on applying imaging-based optimization metrics to...

Tackling calcified lesions with IVUS guidance and optimisation

Bleeding and thrombotic risk in LAA closure patients

20 May 2026 – From EuroPCR 2026

This session provides a thorough examination of bleeding and thrombotic risks in patients undergoing left atrial appendage (LAA) closure. It reviews risk factors for device-related thrombosis, compares anticoagulation strategies post-procedure, and presents real-world clinical outcomes, particularly in high bleeding risk populations and special groups such as...

Didn’t find what you were looking for?